Experience
Geron Corp.
D’Amour
Member of team that represented Geron Corporation in interference related to cell cultures with definitive endoderm cells.
Geron Corp. v. D’Amour, Interference No. 105,734, USPTO, Judges McKelvey, Schafer, Green
Alliance for Sustainable Energy, LLC
Priority of invention resolved by the PTO
Genetics Institute
PQ Corp. v. Johnson Matthey PLC
PQ Corp.
Universal Electronics, Inc. v. Caavo Inc.
Caavo Inc.
Forward Pharma IP APS v. Biogen MA, Inc.
Biogen MA, Inc.
Interference decision reversed in favor of Phillips’s defibrillator patent
Koninklijke Philips Electronics
Sequenom, Inc. et al
Finnegan secures an award of priority in transdermal drug delivery interference
Minnesota Mining and Manufacturing Co.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.